Celgene reports first quarter 2017 financial results
Celgene reported net income of $941 million and diluted EPS of $1.16 for the 2017 first quarter versus GAAP net income of $801 million and diluted EPS of $0.99 in the same 2016 period. Net product sales were $2,950 million for the 2017 first quarter, an 18 percent increase from the same 2016 period. April 27, 2017